Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/13/2000CN1276379A Polypeptide-thyrocalcitonin 11 and polynucleotide for coding same
12/13/2000CN1276244A 口服水解蛋白液 Oral liquid protein hydrolyzate
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/13/2000CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors
12/13/2000CN1059436C Benzoazepine-benzooxaazepine-benzothiaazepin-N-acetate deriv.
12/12/2000US6160176 Anticoagulant agents
12/12/2000US6160108 Platelet activation protein
12/12/2000US6160100 Treatment for wilt diseases of trees
12/12/2000US6160098 Preparing a fixed erythrocyte transport protein having preferential physical properties; obtain deoxygenated erythrocyte transport protein and controlling physical properties of solution during fixation
12/12/2000US6160097 Regenerating active human polypeptides; freeze liquid containing human polypeptide, lipid and detergent, at a later time melt the liquid
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6160093 Microorganism polypeptide; for the prevention, treatment and diagnosis of microorganismal infection; for use in immunotherapy; anticarcinogenic agents
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses
12/12/2000US6160024 Photoactivated antiviral and antitumor compositions
12/12/2000US6160006 Inhibits the activity of the cytochrome p450 3a sub-family of enzymes, specifically, cyp3a4
12/12/2000US6159983 Method and composition for treatment of inflammatory bowel disease
12/12/2000US6159958 Treatment or prophylaxis of retinal pathology and spinal cord injury
12/12/2000US6159950 Promoting hair growth on mammals skins, vectors and dna sequences
12/12/2000US6159949 Polynucleotides, codes and amino acid sequences
12/12/2000US6159948 Therapeutic and drug screening methods for the treatment and prevention of neuronal disease
12/12/2000US6159947 Isolation of nucleic acids and gene codes
12/12/2000US6159940 Administering peptides
12/12/2000US6159938 Serine protease inhibitors comprising α-keto heterocycles
12/12/2000US6159937 Immunomodulators
12/12/2000US6159936 Microbiocides or viricides
12/12/2000US6159935 Method for preventing diarrhea
12/12/2000US6159934 Use of GHRH-RP to stimulate stem cell factor production
12/12/2000US6159933 Emulsion preconcentrate comprising a cyclosporin, propylene carbonate, and glycerides
12/12/2000US6159932 Avermectin macrocyclic lactones and peptides
12/12/2000US6159930 Pharmaceutical composition comprising albumin as an active ingredient
12/12/2000US6159751 Development of DNA probes and immunological reagents of human tumor associated antigens
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159731 Daxx, a Fas-binding protein that activates JNK and apoptosis
12/12/2000US6159723 Renin-active substance
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159712 Methods for enhancing the production of interferon in cell culture
12/12/2000US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis
12/12/2000US6159700 Method of finding agonist and antagonist to human and rat GPR14
12/12/2000US6159697 Antisense modulation of Smad7 expression
12/12/2000US6159696 Isolated human BMP-4 promoter region
12/12/2000US6159694 Antisense modulation of stat3 expression
12/12/2000US6159692 Enzymatic nucleic acid which specifically cleaves rna of the nef gene; viricides
12/12/2000US6159690 Digesting parent polynucleotide with exonuclease, contacting fragments with template under annealing conditions, then amplifying to generate polynucleotides which encode protein motifs with altered characteristics; enzymes; antibodies
12/12/2000US6159684 Drug screening of viricides against human immunodeficiency virus; contacting tat, pol ii and hiv promoter sequences linked to gene with compound which blocks tat binding to cyclin-dependent kinase-7, then detecting gene expression
12/12/2000US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof
12/12/2000US6159496 Keratin-based hydrogel for biomedical applications and method of production
12/12/2000US6159495 Used as a wound dressing, a tissue-engineering scaffold, a diffusion membrane, a coating for implantable devices, a cell encapsulant, and a cross-linked implantable biomaterial for soft and hard tissue replacement
12/12/2000US6159490 Pharmaceutical implant for the delivery of an effective amount of a bioactive peptide or peptide analog over a period of 1 to 12 months
12/12/2000US6159468 Activated protein C formulations
12/12/2000US6159463 Lymphocyte chemoattractant factor
12/12/2000US6159462 Stimulating proliferation or differentiation of cells
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000US6159460 Method for treating interleukin-1 mediated diseases
12/12/2000US6159447 In oral cavity; immobilized enzyme
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000US6159174 Method of using lectins for therapy of diseases transmittable by sexual contact
12/12/2000US6159016 Method and system for producing personal golf lesson video
12/12/2000CA2191754C Modification of clostridial toxins for use as transport proteins
12/12/2000CA2131186C Isosteric antiherpes peptide derivatives
12/12/2000CA2126299C Parathyroid hormone analogues for the treatment of osteoporosis
12/12/2000CA2120506C Treatment of ocular inflammation by blockage of cell adhesion molecules
12/12/2000CA2058560C Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
12/12/2000CA2036413C Hiv protease inhibitors
12/12/2000CA2036397C Hiv protease inhibitors containing derived amino acid units
12/12/2000CA2014948C Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity
12/12/2000CA1341152C Receptor protein for human b cell stimulatory factor-2
12/11/2000CA2274414A1 Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
12/10/2000CA2308036A1 Analogues of lipopolysaccharide-binding protein (lbp)-derived peptides that efficiently neutralize lipopolysaccharides (lps)
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073791A1 Remedies for kidney diseases and method for screening the same
12/07/2000WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence
12/07/2000WO2000073502A2 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
12/07/2000WO2000073482A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000WO2000073478A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
12/07/2000WO2000073477A1 Methods for induction of tolerance to adenoviral vectors and transgene products
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073467A1 Snf2 related cbp activator protein (srcap)
12/07/2000WO2000073465A1 Peptides capable of inducing hiv-specific ctl and preventives/remedies for aids containing the peptides
12/07/2000WO2000073464A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000WO2000073463A1 Groel muteins with improved stability
12/07/2000WO2000073460A2 Modified cytokine for its stabilisation
12/07/2000WO2000073459A1 Four-helical bundle protein zsig81
12/07/2000WO2000073457A1 Mammalian interleukin-10 homologs: il-d110 and il-d210
12/07/2000WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY
12/07/2000WO2000073455A1 Biosynthesis of foreign proteins using transformed microalgae
12/07/2000WO2000073454A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/07/2000WO2000073453A1 T-bet compositions and methods of use thereof
12/07/2000WO2000073452A2 Compositions and methods for the treatment of immune related diseases
12/07/2000WO2000073451A1 Mammalian receptor proteins; related reagents and methods
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073448A1 Adipocyte complement related protein homolog zacrp7
12/07/2000WO2000073447A1 RinTinTin, A CHEMOKINE
12/07/2000WO2000073446A2 Adipocyte complement related protein homolog zacrp6
12/07/2000WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3)
12/07/2000WO2000073444A1 Adipocyte complement related protein homolog zacrp5
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073441A1 GENE Any-RF, DORMANCY REGULATORY SUBSTANCE, PROCESS FOR PRODUCING THE SAME AND CELL REGULATOR FOR VITAL CELLS
12/07/2000WO2000073433A1 Screening method for peptides
1 ... 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 ... 3163